Bullish and bearish opinions expressed in this episode, paired with supporting transcript quotes. The quote confirms what was said—not whether the opinion is correct.
Bullish
$GENDIAG— Genetic diagnostics sector has been a huge success with ongoing dividends from genomic advances, exemplified by portfolio company Natera's growth from $1M seed to $22B market cap as the leading provider of prenatal testing, oncology recurrence monitoring, and organ transplant protection testing
$PANW— Palo Alto Networks, incubated inside Sequoia's office, has achieved 10x returns as a public company, exemplifying the value of holding winners longer post-IPO
$NOW— ServiceNow has achieved 10x returns as a public company, demonstrating the value of patient capital and holding positions longer post-IPO
$MDB— MongoDB has achieved 10x returns as a public company, justifying Sequoia's new strategy of holding positions longer post-IPO
$HUBS— HubSpot has achieved 10x returns as a public company, demonstrating the value of patient capital in the public markets
$STABLES— Portfolio company thriving due to favorable stablecoin regulation, benefiting from regulatory clarity in the space
$LATAMTECH— Chinese entrepreneurs are migrating to Latin America and other markets, bringing entrepreneurial talent and potentially creating new opportunities in these regions
Bearish
$VC— Venture capital is 'return free risk' with the industry needing $700B+ in annual returns but only ~20 companies per decade achieving $1B+ exits, making it a poor investment for most investors
$CHINASTARTUP— Chinese startup ecosystem has collapsed with a 98% reduction in company formations from 51,000 in 2018 to just 1,200 in 2023 due to regulatory uncertainty